Prestige Brands (NYSE: PBH) has closed a deal for private equity-backed Insight Pharmaceuticals, the maker of home pregnancy test EPT and medication Monistat, for $750 million. 

Revose, Pennsylvania-based Insight sells over-the-counter products, including women's health and personal-care products.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.